- Home
- ABEO vs EMF Comparison
ABEO vs EMF Comparison
Compare ABEO & EMF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- EMF
- Stock Information
- Founded
- ABEO 1974
- EMF 1987
- Country
- ABEO United States
- EMF United States
- Employees
- ABEO N/A
- EMF N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- EMF Finance/Investors Services
- Sector
- ABEO Health Care
- EMF Finance
- Exchange
- ABEO Nasdaq
- EMF Nasdaq
- Market Cap
- ABEO 281.0M
- EMF 254.5M
- IPO Year
- ABEO 1980
- EMF N/A
- Fundamental
- Price
- ABEO $4.36
- EMF $17.73
- Analyst Decision
- ABEO Strong Buy
- EMF
- Analyst Count
- ABEO 5
- EMF 0
- Target Price
- ABEO $18.20
- EMF N/A
- AVG Volume (30 Days)
- ABEO 1.5M
- EMF 29.3K
- Earning Date
- ABEO 11-13-2025
- EMF 01-01-0001
- Dividend Yield
- ABEO N/A
- EMF 6.16%
- EPS Growth
- ABEO N/A
- EMF N/A
- EPS
- ABEO 0.99
- EMF N/A
- Revenue
- ABEO $400,000.00
- EMF N/A
- Revenue This Year
- ABEO N/A
- EMF N/A
- Revenue Next Year
- ABEO $324.71
- EMF N/A
- P/E Ratio
- ABEO $4.41
- EMF N/A
- Revenue Growth
- ABEO N/A
- EMF N/A
- 52 Week Low
- ABEO $3.93
- EMF $10.58
- 52 Week High
- ABEO $7.54
- EMF $12.67
- Technical
- Relative Strength Index (RSI)
- ABEO 24.72
- EMF 66.70
- Support Level
- ABEO $5.29
- EMF $17.50
- Resistance Level
- ABEO $5.41
- EMF $18.01
- Average True Range (ATR)
- ABEO 0.24
- EMF 0.24
- MACD
- ABEO -0.08
- EMF 0.03
- Stochastic Oscillator
- ABEO 3.49
- EMF 78.90
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About EMF Templeton Emerging Markets Fund
Templeton Emerging Markets Fund is a closed-end management investment company. It seeks long-term capital appreciation by investing, under normal market conditions, at least 80% of its net assets in emerging country equity securities. It invests in various sectors such as Pharmaceuticals, Beverages, Broadline Retail, Metals &Mining, Banks, Food Products, Semiconductors & Semiconductor Equipment, insurance, Entertainment, and others.